21 – 30 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
(
- Contribution to journal › Article
-
Mark
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
(
- Contribution to journal › Article
-
Mark
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
(
- Contribution to journal › Article
- 2010
-
Mark
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR).
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
(
- Contribution to journal › Article
- 2008
-
Mark
MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.622-622(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.822-822(
- Contribution to journal › Published meeting abstract
-
Mark
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
(
- Contribution to journal › Article
-
Mark
Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.821-821(
- Contribution to journal › Published meeting abstract